Jesy Nelson Advocates for Newborn screening of Spinal Muscular Atrophy Following Premature Birth of Twins
Jesy Nelson, the former Little Mix star, is championing a crucial cause: expanding newborn screening to include Spinal Muscular Atrophy (SMA). Her advocacy comes after the premature birth of her twin daughters, bringing a deeply personal dimension to this critical health issue. Nelson’s experience has ignited her passion to ensure other families don’t face the agonizing delays in diagnosis that can significantly impact a child’s future.
Understanding Spinal Muscular Atrophy
Spinal Muscular Atrophy is a progressive genetic condition that affects motor neurons, leading to muscle weakness and wasting.It can be devastating, potentially causing death within the first two years of life if left untreated. However, early diagnosis and intervention are dramatically changing the outlook for babies born with SMA.
Here’s what you need to know:
* Genetic Basis: Approximately one in 40 people carry the altered gene responsible for SMA, though most are unaware.
* Severity Varies: The condition presents with varying degrees of severity, impacting muscle strength and function.
* Time is Critical: Irreversible nerve damage can occur if treatment isn’t initiated promptly, highlighting the urgency of early detection.
* Estimated Incidence: Around 47 babies are born with SMA in the UK each year.
A Breakthrough in Treatment: Zolgensma
Fortunately, a groundbreaking gene therapy drug called Zolgensma offers hope.Approved by the National Health Service (NHS) in 2021, Zolgensma delivers a functional copy of the affected gene directly to the body. This innovative treatment can halt the progression of the disease and significantly improve a child’s quality of life.
However, the effectiveness of Zolgensma is maximized when administered before substantial nerve damage occurs.This underscores the vital importance of early diagnosis.
The Call for Universal Newborn Screening
Currently, SMA screening in the UK is limited to babies with a sibling already diagnosed with the condition. Advocates, including Nelson, are pushing for the inclusion of SMA in the standard newborn blood spot test. This test already screens for ten other rare but serious conditions, and adding SMA would be a game-changer.
Imagine the impact:
* Faster Diagnosis: Identifying affected babies within days of birth, rather than months.
* Earlier intervention: Allowing for immediate access to life-altering treatments like Zolgensma.
* Improved Outcomes: Maximizing the potential for a healthier, more fulfilling life for children with SMA.
Nelson’s Personal Connection and advocacy
Nelson, 34, experienced rare complications during her pregnancy and delivered her twins prematurely at 31 weeks. She openly shared her feelings of pride in her body after the birth, emphasizing the amazing strength and resilience of motherhood.
Her personal journey has fueled her commitment to raising awareness about SMA and advocating for universal screening. Nelson wants to empower other parents by ensuring their children receive a diagnosis as quickly as possible,giving them the best possible chance at a healthy future.
You can learn more about Spinal Muscular Atrophy and the work of SMA UK by visiting their website. Together, we can make a difference in the lives of children and families affected by this challenging condition.
Keep reading